During the nearly 50 years that Reinhardt was at the University, he was regarded as one of the most influential health economists and health policy experts in the country, known for his ability to ...

Decades of advances in medical technology and public health are causing global populations to age. While achieving longer lives is certainly a net positive, this demographic shift is placing an ...

Over the past year, several global biopharmaceutical firms have substantially reorganized their health economics and outcomes research (HEOR) groups. Specifically, the leaders of the groups have been ...

Rob Abbott, CEO, ISPOR, explains how health economics and outcomes research is helping healthcare systems measure the true value of treatments, improve patient outcomes, and address rising drug costs ...

The University Senate unanimously approved a new Master of Science program in health economics and policy for the Mailman School of Public Health during the October plenary meeting, with 64 votes in ...

Our researchers apply their expertise in health economics, oncology, behavioral science, clinical psychology and health services research to address several multidimensional challenges: identifying ...

Health economics provides a framework for evaluating the allocation of limited resources in healthcare, ensuring that interventions not only deliver clinical benefit but also represent optimal use of ...

The Ph.D. program in Managerial Economics & Strategy (MECS), a program offered jointly by the Departments of Managerial Economics & Decision Sciences (MEDS) and Strategy, emphasizes the use of ...